Literature DB >> 23119821

Cervical node metastasis in Carcinoma of Pyriform Sinus: A prospective analysis of prevalence and distribution.

S Saxena1, N Sonkhya, P Mishra, R Yadav, A S Bapna.   

Abstract

The present study included 28 cases of carcinoma of pyriform sinus admitted in ENT ward of SMS Hospital in year 2000. The present work has been undertaken to analyse the prevalence and distribution of cervical lymph node metastases in cases of Pyriform sinus carcinoma, to compare the incidence and distribution of lymph node metastasis in medial vs lateral wall pyriform sinus carcinoma and to review the case of pyriform sinus carcinoma in reference to symptoms, clinical features and histopathological tumor staging.Most of the patients were in 6(th) decade of life. Sex incidence observed was male 93% and female 7% Histological variety was moderately differentiated squamous cell carcinoma (46.5%) which differs from the previous studies reporting the commonest variety to be poorly differentiated squamous cell carcinoma.It was observed in this series that 60% cases were of malignancy medial wall of pyriform fossa and 40% cases were of both lateral and medial wall. In contrast to previous studies which suggested that chances of contralateral cervical metastases was more with carcinoma involving medial wall of pyriform sinus, we observed equal incidence of contralateral node metastases in both group of pyriform sinus carcinoma case.In the present study 75% cases presented to us with T(4) stage. Though there were 4 cases of T(1) tumor in present series but none were in TNM stage I or II. This indicates that there is essentially no difference in the risk of lymph node metastases by T-stage.

Entities:  

Year:  2001        PMID: 23119821      PMCID: PMC3450500          DOI: 10.1007/BF02991546

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  11 in total

1.  Carcinoma of the pyriform sinus a comparison of treatment modalities.

Authors:  K J Eisbach; C J Krause
Journal:  Laryngoscope       Date:  1977-11       Impact factor: 3.325

2.  Aggressive surgical management of pyriform sinus carcinoma. A 15 year experience.

Authors:  T M Sasaki; H W Baker; R A Yeager; D B McConnell; R M Vetto
Journal:  Am J Surg       Date:  1986-05       Impact factor: 2.565

3.  Radical irradiation for carcinoma of the pyriform sinus.

Authors:  R R Million; N J Cassisi
Journal:  Laryngoscope       Date:  1981-03       Impact factor: 3.325

4.  Squamous cell carcinoma of the pyriform sinus.

Authors:  S A El Badawi; H Goepfert; G H Fletcher; J Herson; M J Oswald
Journal:  Laryngoscope       Date:  1982-04       Impact factor: 3.325

5.  Prognostic value of histopathologic parameters and DNA flow cytometry in squamous cell carcinoma of the pyriform sinus.

Authors:  A Del Valle-Zapico; F F Fernández; A R Suárez; C M Angulo; J R Quintela
Journal:  Laryngoscope       Date:  1998-02       Impact factor: 3.325

6.  Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites.

Authors:  I Kato; A M Nomura; G N Stemmermann; P H Chyou
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

7.  Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution.

Authors:  J G Buckley; K MacLennan
Journal:  Head Neck       Date:  2000-07       Impact factor: 3.147

8.  Medial vs lateral wall pyriform sinus carcinoma: implications for management of regional lymphatics.

Authors:  J T Johnson; G W Bacon; E N Myers; R L Wagner
Journal:  Head Neck       Date:  1994 Sep-Oct       Impact factor: 3.147

9.  Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.

Authors:  J G Spector; D G Sessions; B Emami; J Simpson; B Haughey; J Harvey; J M Fredrickson
Journal:  Laryngoscope       Date:  1995-04       Impact factor: 3.325

10.  Cancer and non-cancer controls in studies on the effect of tobacco and alcohol consumption.

Authors:  S Barra; A E Barón; S Franceschi; R Talamini; C La Vecchia
Journal:  Int J Epidemiol       Date:  1991-12       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.